TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
23 hedge funds and large institutions have $795K invested in Titan Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
Holders
23
Holding in Top 10
–
Calls
$84K
Puts
–
Top Buyers
| 1 | +$65K | |
| 2 | +$50K | |
| 3 | +$32.2K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12.6K |
Top Sellers
| 1 | -$202K | |
| 2 | -$14K | |
| 3 | -$10K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$9K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$5K |